These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6759952)

  • 1. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
    Kutyrina IM; Androsova SO; Warshavskii VA; Tareyeva IE
    Nephron; 1982; 32(3):244-8. PubMed ID: 6759952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
    Tan SY; Shapiro R; Franco R; Stockard H; Mulrow PJ
    Ann Intern Med; 1979 May; 90(5):783-5. PubMed ID: 434681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
    Kutyrina IM; Nikishova TA; Tareyeva IE
    Nephrol Dial Transplant; 1987; 2(4):219-23. PubMed ID: 3118260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
    Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
    Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
    Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A
    J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term treatment with indomethacin on renal function.
    Ruilope LM; Garcia Robles R; Paya C; Alcazar JM; Miravalles E; Sancho-Rof J; Rodicio J; Knox FG; Romero JC
    Hypertension; 1986 Aug; 8(8):677-84. PubMed ID: 3525404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating renin and aldosterone levels in children with organic acidemia-therapeutic experience with fludrocortisone.
    Tarçın G; Ahmadzada S; Saygılı S; Kaya A; Aktuğlu Zeybek AÇ; Ercan O
    Eur J Pediatr; 2023 Dec; 182(12):5447-5453. PubMed ID: 37773296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin on renal function in normotensive patients with chronic glomerulonephritis with preserved renal function.
    Nielsen CB; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1994 Nov; 54(7):523-9. PubMed ID: 7863229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease.
    Reubi FC; Weidmann P; Glück Z
    Klin Wochenschr; 1979 Dec; 57(23):1273-85. PubMed ID: 397972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyporeninemic hypoaldosteronism in children with chronic renal failure.
    Rodríguez-Soriano J; Vallo A; Sanjurjo P; Castillo G; Oliveros R
    J Pediatr; 1986 Sep; 109(3):476-82. PubMed ID: 3528445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin and aldosterone in hypothyroidism: relation to excretion of sodium and potassium.
    Saruta T; Kitajima W; Hayashi M; Kato E; Matsuki S
    Clin Endocrinol (Oxf); 1980 May; 12(5):483-9. PubMed ID: 7000394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of renal prostaglandin E2 in chronic renal disease hypertension.
    Ruilope L; Garcia Robles P; Bernis C; Barrientos A; Alcazar J; Tresguerres JA; Sancho J; Rodicio JL
    Nephron; 1982; 32(3):202-6. PubMed ID: 6759949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
    Radó JP; Boer P
    Endokrinologie; 1979 Apr; 73(2):173-85. PubMed ID: 467373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney.
    Mitnick PD; Greenberg A; DeOreo PB; Weiner BM; Coffman TM; Walker BR; Agus ZS; Goldfarb S
    Clin Pharmacol Ther; 1980 Nov; 28(5):680-9. PubMed ID: 7002426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet.
    Pedrinelli R; Magagna A; Salvetti A
    Eur J Clin Invest; 1982 Apr; 12(2):107-11. PubMed ID: 6807681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normotensive hyperreninemia in systemic lupus erythematosus. An indicator of tubular dysfunction.
    Herrera-Acosta J; Guerrero J; Erbessd ML; Paz-Barahona M; Chessal F; Alarcón-Segovia D; Peña JC
    Nephron; 1978; 22(1-3):128-37. PubMed ID: 745633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome.
    Usberti M; Gazzotti RM
    Am J Nephrol; 1998; 18(3):251-5. PubMed ID: 9627045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyporeninemic hypoaldosteronism syndrome caused by indomethacin].
    Kutyrina IM; Androsova SO; Li Chun Khi
    Klin Med (Mosk); 1980 May; 58(5):27-30. PubMed ID: 6991804
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of the nephrotic syndrome with indomethacin.
    Donker AJ; Brentjens JR; van der Hem GK; Arisz L
    Nephron; 1978; 22(4-6):374-81. PubMed ID: 740100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.